Israel - hebreo - Ministry of Health

אגנטק (1987) בע"מ - מומחה - מעבדות ביוכימיות ומיקרו ביולוגיות בבתי חולים

Israel - hebreo - Ministry of Health

fischer pharmaceuticals ltd - povidone-iodine - תמיסה - חיצוני - povidone-iodine 7.5 %w/v - povidone-iodine - povidone-iodine - wound disinfection to prevent skin infections caused by bacteria and fungi, disinfection of infected skin conditions and sidinfection of the hands before medical procedures.

Israel - hebreo - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methylprednisolone acetate - תרחיף להזרקה - methylprednisolone acetate 40 mg/ml - methylprednisolone - methylprednisolone - for the treatment of conditions responsive to steroid injection therapy.

Israel - hebreo - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - hebreo - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 15 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - hebreo - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - טבליות ניתנות לפיזור - aciclovir 800 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox in the following groups: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving short or intermittent courses of aerosolized corticosteroids.

Israel - hebreo - Ministry of Health

cts chemical industries ltd, israel - aciclovir - טבליה - aciclovir 200 mg - aciclovir - aciclovir - treatment of herpes simplex, infections of skin and mucous membranes including initial and recurrent genital herpes. suppression of recurrent herpes simplex infections. prophylaxis of herpes simplex infections in immune compromised patients. treatment of herpes zoster infections. for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: patients over 13 years of age who are otherwise healthy. children over 12 months of age with chronic cutaneous or pulmonary condition, or receiving long term salicylate therapy. children receiving short or intermittent courses of aerosolized corticosteroids. the drug should not be taken if more than 24 hours passed from the onset of a typical chickenpox rash.

Israel - hebreo - Ministry of Health

cts chemical industries ltd, israel - aciclovir - טבליה - aciclovir 400 mg - aciclovir - aciclovir - treatment of herpes simplex, infections of skin and mucous membranes including initial and recurrent genital herpes. suppression of recurrent herpes simplex infections. prophylaxis of herpes simplex infections in immune compromised patients. treatment of herpes zoster infections. for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: patients over 13 years of age who are otherwise healthy. children over 12 months of age with chronic cutaneous or pulmonary condition, or receiving long term salicylate therapy. children receiving short or intermittent courses of aerosolized corticosteroids. the drug should not be taken if more than 24 hours have passed from the onset of a typical chickenpox rash.

Israel - hebreo - Ministry of Health

tzamal bio-pharma ltd - busulfan - תמיסה להזרקה - busulfan 60 mg / 10 ml - busulfan - busulfan - for use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to hematopoietic progenitor cell transplantation.

Israel - hebreo - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate; tobramycin - תרחיף לעין - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infect